Elucidation of Toll-like receptor and adapter protein signaling in vascular dysfunction induced by Gram-positive Staphylococcus aureus or Gram-negative Escherichia coli

Shock

Volumn 27, Issue 1, 2007, Pages 40-47

  Cartwright, Neil ^a   McMaster, Shaun K ^a   Sorrentino, Rosalinda ^a   Paul Clark, Mark ^a   Sriskandan, Shiranee ^b   Ryffel, Bernhard ^c   Quesniaux, Valerie F J ^c   Evans, Timothy W ^a   Mitchell, Jane A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CNRS   (France)

Author keywords

Bacteria; MyD88; Nitric oxide synthase II; Toll like receptors; TRIF; Tumor necrosis factor; Vascular biology

Indexed keywords

ADAPTOR PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; ENZYME INDUCTION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STAPHYLOCOCCUS AUREUS; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; ESCHERICHIA COLI; MACROPHAGES; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE II; RATS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTORS; VASCULAR DISEASES;

EID: 33845706499     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000235127.59492.db     Document Type: Article

References (32)

1. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K: Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 31(9):2332-2338, 2003.
2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546-1554, 2003.
3. Lin WJ, Yeh WC: Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. Shock 24(3):206-209, 2005.
4. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189(4):615-625, 1999.
5. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al.: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282(5396):2085-2088, 1998.
6. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162(7):3749-3752, 1999.
7. Vogel SN, Fitzgerald KA, Fenton MJ: TLRs: differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 3(8):466-477, 2003.
8. Paul-Clark M, McMaster SK, Belcher E, Sorrentino R, Anandarajah J, Fleet M, Sriskandan S, Mitchell JA: Differential effects of Gram positive versus Gram negative bacteria on NOSII and TNFα in macrophages: role of TLRs in synergy between the two. Br J Pharmacol. In press.
9. Kim HW, Greenburg AG: Nitric oxide scavenging, alone or with nitric oxide synthesis inhibition, modulates vascular hyporeactivity in rats with intraperitoneal sepsis. Shock 17(5):423-426, 2002.
10. Palmer RM, Rees DD, Ashton DS, Moncada S: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153(3):1251-1256, 1988.
11. Thiemermann C, Wu CC, Szabo C, Perretti M, Vane JR: Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br J Pharmacol 110(1):177-182, 1993.
12. Michelsen KS, Doherty TM, Shah PK, Arditi M: TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 173(10):5901-5907, 2004.
13. Jimenez R, Belcher E, Sriskandan S, Lucas R, McMaster S, Vojnovic I, Warner TD, Mitchell JA: Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle. Proc Natl Acad Sci U S A 102(12):4637-4642, 2005.
14. Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA: Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br J Pharmacol 121(1):125-133, 1997.
15. Paul-Clark MJ, Gilroy DW, Willis D, Willoughby DA, Tomlinson A: Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. J Immunol 166(2):1169-1177, 2001.
16. Halpern W, Mulvany MJ, Warshaw DM: Mechanical properties of smooth muscle cells in the walls of arterial resistance vessels. J Physiol 275:85-101, 1978.
17. Mulvany MJ, Halpern W: Mechanical properties of vascular smooth muscle cells in situ. Nature 260(5552):617-619, 1976.
18. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B: Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study, ROXIS Study Group. Lancet 350(9075):404-407, 1997.
19. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ: Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96(2):404-407, 1997.
20. Baumgarten G, Knuefermann P, Schuhmacher G, Vervolgyi V, von Rappard J, Dreiner U, Fink K, Djoufack C, Hoeft A, Grohe C, et al.: Toll-like receptor 4, nitric oxide, and myocardial depression in endotoxemia. Shock 25(1):43-49, 2006.
21. Takeda K, Takeuchi O, Akira S: Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 8(6):459-463, 2002.
22. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S: Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13(7):933-940, 2001.
23. Belcher E, Evans T, Sriskandan S, Mitchell J: Gram-positive Staphylococcus aureus contrasts with Gram-negative Escherichia coli in the induction of tumour necrosis factor-alpha and nitric oxide from macrophages. Br J Anaesth 9:540-541, 2003.
24. Kuo CT, Chiang LL, Lee CN, Yu MC, Bai KJ, Lee HM, Lee WS, Sheu JR, Lin CH: Induction of nitric oxide synthase in RAW 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus: involvement of protein kinase C- and nuclear factor-kB-dependent mechanisms. J Biomed Sci 10(1):136-145, 2003.
25. Hattor Y, Kasai K, Akimoto K, Thiemermann C: Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway. Biochem Biophys Res Commun 233(2):375-379, 1997.
26. Kengatharan M, De Kimpe SJ, Thiemermann C: Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br J Pharmacol 117(6):1163-1170, 1996.
27. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci U S A 97(25):13766-13771, 2000.
28. Morr M, Takeuchi O, Akira S, Simon MM, Muhlradt PF: Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. 32(12):3337-3347, 2002.
29. Nakao Y, Funami K, Kikkawa S, Taniguchi M, Nishiguchi M, Fukumori Y, Seya T, Matsumoto M: Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells. J Immunol 174(3):1566-1573, 2005.
30. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S: Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169(1):10-14, 2002.
31. Buwitt-Beckmann U, Heine H, Wiesmuller KH, Jung G, Brock R, Akira S, Ulmer AJ: TLR1- and TLR6-independent recognition of bacterial lipoeptides. J Biol Chem 281(14):9049-9057, 2006.
32. Lorente JA, Marshall JC: Neutralization of tumor necrosis factor in preclinical models of sepsis. Shock 24(suppl 1):107-119, 2005.